Prescription RequiredBivalirudin is a rapidly acting anticoagulant used in hospitals to prevent harmful blood clotting during procedures that open blocked coronary arteries. It may be selected as an alternative to heparin for certain patients undergoing angioplasty or percutaneous coronary intervention.
| Generic Name | Bivalirudin |
| Strength | 250 mg |
| Manufacturer | Abbott |
| Packing | 1 vial |
| Prescribed For | Treatment and prevention of blood clots |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |
Bivalirudin directly blocks thrombin, an enzyme that converts fibrinogen into fibrin during blood-clot formation. It can inhibit both circulating thrombin and thrombin already attached to a clot. This helps prevent dangerous clotting during coronary procedures.
Bivalirudin prices may vary between countries depending on the brand, strength, pack size, pharmacy, insurance coverage, government subsidies, taxes and local healthcare policies. The following resources provide country-specific pricing, reimbursement, regulatory or medicine information.
